pharmaceuticals

The pharmaceutical company Biontech, known for its Covid-19 vaccine, is making progress in the development of a cancer drug. The biotech company is collaborating with Bristol Myers Squibbin this endeavour. In addition, Biontech is about to acquire its former rival Curevac.

Biontech is acquiring Curevac at just the right time. The Purchase Agreement was unanimously approved by both BioNTech’s and CureVac’s management and supervisory boards.

Higher, faster, further: Shop Apotheke is growing rapidly thanks to e-prescriptions. But growth comes at a price in the form of high marketing costs. CEO Olaf Heinrich explains the strategy to Börsen-Zeitung.

Stefan Oelrich, Member of Bayer's Board of Management and Head of the Pharmaceuticals Division, is confident about the development pipeline. As one important patent expires, he points to a range of new products that will generate big sales.

Long-suffering Bayer shareholders are being asked to stump up 8 billion euros in a cash call. What looks like a bold move might just be courage born out of desperation.